AVR 1.73% $17.05 anteris technologies ltd

Ann: HSV-2 Phase IIa Results Investor Webinar, page-135

  1. 204 Posts.
    lightbulb Created with Sketch. 7
    Could be a tricky one for a partner as they may want to be involved for HPV but not so much for HSV. Wonder if the legal hurdles mentioned in the email last week had anything to do with this.
    Does anyone know given it is a platform tech whether a partner could have the rights for one and the option for the second pending result
    All spec on my part.
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
(20min delay)
Last
$17.05
Change
-0.300(1.73%)
Mkt cap ! $327.7M
Open High Low Value Volume
$17.00 $17.44 $16.95 $184.6K 10.84K

Buyers (Bids)

No. Vol. Price($)
1 191 $17.15
 

Sellers (Offers)

Price($) Vol. No.
$17.50 500 1
View Market Depth
Last trade - 15.59pm 19/07/2024 (20 minute delay) ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.